Plain-English translation of NCT07782450 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
Pfizer
Collaborators
Syneos
Enrollment target
~54 participants
Started
October 2026
Primary completion
February 2031
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pfizer CT.gov Call Center
Pfizer
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.